26.03.2025 12:45 | ONC | Appointment of Administrators & Nomad Resignation | RNS |
19.03.2025 07:00 | ONC | Holding(s) in Company | RNS |
17.03.2025 14:29 | ONC | Oncimmune enters administration after failing to sell subsidiary | Alliance |
17.03.2025 07:30 | ONC | Suspension - Oncimmune Holdings Plc | RNS |
17.03.2025 07:00 | ONC | Intention to Appoint Administrators and Suspension | RNS |
14.03.2025 07:00 | ONC | Block Listing Return | RNS |
10.03.2025 13:39 | ONC | Result of GM | RNS |
03.03.2025 16:38 | OHGR, ONC, MIO | UK shareholder meetings calendar - next 7 days | Alliance |
27.02.2025 16:18 | ONC | Result of AGM | RNS |
24.02.2025 07:00 | ONC | Strategic update | RNS |
20.02.2025 14:16 | AEG, ONC, IHP | UK shareholder meetings calendar - next 7 days | Alliance |
18.02.2025 07:00 | ONC | Holding(s) in Company | RNS |
12.02.2025 07:01 | ONC | Block Listing Return | RNS |
12.02.2025 07:00 | ONC | Posting of Notice of General Meeting | RNS |
10.02.2025 10:43 | ONC | Oncimmune forecasts 33% revenue growth in 2025 after doubling in 2024 | Alliance |
10.02.2025 07:00 | ONC | Final Results | RNS |
04.02.2025 10:38 | ONC | Holding(s) in Company | RNS |
03.02.2025 07:00 | ONC | Notice of Annual General Meeting | RNS |
31.01.2025 10:19 | NWT, ONC, TRB | AIM WINNERS & LOSERS: Tribal expects "positive" 2024; Newmark falls | Alliance |
31.01.2025 09:58 | ONC | IN BRIEF: Oncimmune shares dive; laments slow conversion of contracts | Alliance |
31.01.2025 07:00 | ONC | Trading Update | RNS |
04.12.2024 13:38 | ONC | Holding(s) in Company | RNS |
13.11.2024 17:06 | ONC | Holding(s) in Company | RNS |
13.11.2024 11:41 | ONC | Holding(s) in Company | RNS |
12.11.2024 17:17 | ONC | Holding(s) in Company | RNS |
12.11.2024 16:49 | ONC | Holding(s) in Company | RNS |
11.11.2024 11:15 | ONC | Director/PDMR Shareholding | RNS |
08.11.2024 14:37 | ONC | Results of General Meeting and Total Voting Rights | RNS |
01.11.2024 13:31 | ONC, AYM | UK shareholder meetings calendar - next 7 days | Alliance |
31.10.2024 17:07 | ONC | Result of Retail Offer | RNS |
31.10.2024 14:09 | ONC | Oncimmune Holdings shares tick up as notes new contracts | Alliance |
31.10.2024 07:00 | ONC | Trading Update | RNS |
23.10.2024 16:12 | ONC | Posting of Circular and Notice of General Meeting | RNS |
21.10.2024 12:30 | ONC | UPDATE: Oncimmune raises GBP2.2 million in equity as planned | Alliance |
18.10.2024 15:05 | ONC | Result of Placing & Issue of Equity | RNS |
18.10.2024 12:44 | ONC | IN BRIEF: Oncimmune converts debt and offers shares in growth push | Alliance |
18.10.2024 08:00 | ONC | Retail Offer | RNS |
18.10.2024 07:47 | ONC | Fundraising and Amendments to Facility | RNS |
09.09.2024 11:42 | ONC | Oncimmune expects "substantial" revenue growth following contract wins | Alliance |
09.09.2024 07:00 | ONC | Trading Update | RNS |
02.09.2024 17:35 | ONC | Oncimmune Holdings agrees new contract valued at USD700,000 | Alliance |
02.09.2024 07:00 | ONC | Contract Win | RNS |
09.08.2024 17:15 | EARN, TERN, KINO | TRADING UPDATES: Tan Delta signs contract; Earnz loss widens | Alliance |
09.08.2024 11:21 | ONC, KZG | AIM WINNERS & LOSERS: Hummingbird falls on mining challenges | Alliance |
09.08.2024 07:00 | ONC | US$1.5m Contract Win with Top 10 Pharma Company | RNS |
24.06.2024 11:18 | ONC | Holding(s) in Company | RNS |
17.06.2024 14:30 | ONC | Holding(s) in Company | RNS |
29.05.2024 17:45 | ONC | Holding(s) in Company | RNS |
21.05.2024 16:27 | WRKS, DXRX, TPT | EARNINGS AND TRADING: Topps Tiles in strategic shift as swings to loss | Alliance |
21.05.2024 07:00 | ONC | Interim Results | RNS |
17.05.2024 10:11 | ONC | Investor Presentation via Investor Meet Company | RNS |
09.05.2024 15:08 | ONC | Holding(s) in Company | RNS |
26.04.2024 07:00 | ONC | Appointment of Nominated Adviser and Joint Broker | RNS |
25.04.2024 10:44 | ONC | Holding(s) in Company | RNS |
02.04.2024 11:34 | ONC | Result of General Meeting | RNS |
02.04.2024 08:00 | ONC | Total Voting Rights | RNS |
26.03.2024 11:18 | ONC | Holding(s) in Company | RNS |
13.03.2024 17:32 | ONC | Block Listing Return | RNS |
06.03.2024 15:02 | ONC | Posting of Notice of General Meeting | RNS |
01.03.2024 13:00 | ONC | Investor Presentation via Investor Meet Company | RNS |
29.02.2024 17:00 | MACF, RSE, ONC | EARNINGS: Leeds awaiting Hemmers sale, Macfarlane ups full-year payout | Alliance |
29.02.2024 11:19 | ONC | Holding(s) in Company | RNS |
29.02.2024 07:00 | ONC | Final Results | RNS |
26.02.2024 11:30 | ONC | Result of AGM | RNS |
19.02.2024 12:54 | ONC | UK shareholder meetings calendar - next 7 days | Alliance |
11.12.2023 15:12 | ONC | Director/PDMR Shareholding | RNS |
08.12.2023 14:31 | ONC | Grant of Options and PDMR Dealing | RNS |
30.11.2023 14:25 | ARK, ONC, SBTX | TRADING UPDATES: SkinBio launches food supplement on Amazon | Alliance |
30.11.2023 07:00 | ONC | Progress against Strategy | RNS |
10.11.2023 10:14 | ONC | Holding(s) in Company | RNS |
07.11.2023 16:11 | ONC | Grant of Options and PDMR Dealing | RNS |
19.10.2023 07:00 | ONC | Investor Presentation via Investor Meet Company | RNS |
12.10.2023 14:21 | ONC | IN BRIEF: Oncimmune shares jump following new strategy update | Alliance |
12.10.2023 07:00 | ONC | Update on Strategy & Changes to the Board | RNS |
01.08.2023 07:00 | ONC | Board Changes | RNS |